Portage Biotech
47 Avenue Road
Suite 200
Toronto
Ontario
M5R 2G3
Canada
Tel: 416-929-1806
Fax: 416-929-6612
Website: http://portagebiotech.com/
90 articles with Portage Biotech
-
Portage Biotech Invests In Sentien Biotechnologies Inc.
8/10/2015
-
Portage Biotech's Biohaven Announces IND Filing For Bhv-0223 For Phase 1 Clinical Testing
7/23/2015
-
Portage Biotech Completes Non-Brokered Private Placement In Two Tranches For A Total Proceeds Of US$ 5,155,080
6/25/2015
-
Portage Biotech Announces Proposed Private Placement
5/20/2015
-
Portage Biotech's Biohaven To Begin Phase 1 Study In 3Q2015 And Readying For Phase 3 Study Start By 1Q2016
4/22/2015
-
Portage Biotech's CPP Platform Delivers A Peptide Cargo Across Blood Brain Barrier
4/20/2015
-
Portage Biotech To Present At Master Investor 2015 In London, UK
4/16/2015
-
Portage Biotech's Biohaven Announces Agreement With inVentiv Health
4/1/2015
-
Portage Biotech's Biohaven Enters Into Exclusive Formulation Agreement And Global License With Catalent Pharma Solutions For Lead Product
3/24/2015
-
Portage Biotech Announces Additional Consultants To Expedite Its PPL-003 Development Programs
10/6/2014